|
ZNF45 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.1651018451746E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.97000251853797E-11 |
| Normal-vs-Stage2 |
2.74190000004726E-06 |
| Normal-vs-Stage3 |
3.23000000002072E-06 |
| Normal-vs-Stage4 |
1.704610E-03 |
| Stage1-vs-Stage2 |
9.503000E-01 |
| Stage1-vs-Stage3 |
8.550400E-01 |
| Stage1-vs-Stage4 |
4.910200E-01 |
| Stage2-vs-Stage3 |
8.326400E-01 |
| Stage2-vs-Stage4 |
4.539600E-01 |
| Stage3-vs-Stage4 |
5.727000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17239567948491E-11 |
| Normal-vs-AfricanAmerican |
2.18110000005378E-06 |
| Normal-vs-Asian |
1.278150E-03 |
| Caucasian-vs-AfricanAmerican |
3.347600E-01 |
| Caucasian-vs-Asian |
8.705800E-01 |
| AfricanAmerican-vs-Asian |
8.627200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54285481560146E-12 |
| Normal-vs-Female |
2.981500E-03 |
| Male-vs-Female |
3.597000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.87859999998008E-06 |
| Normal-vs-Extreme_Weight |
7.14539538648751E-13 |
| Normal-vs-Obese |
3.28549999994987E-06 |
| Normal-vs-Extreme_Obese |
1.717900E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.330400E-01 |
| Normal_Weight-vs-Obese |
5.247000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.769000E-01 |
| Extreme_Weight-vs-Obese |
1.278420E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.803600E-01 |
| Obese-vs-Extreme_Obese |
1.786760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.562100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.95860000335091E-08 |
| Normal-vs-Age(61-80Yrs) |
1.72869496495309E-11 |
| Normal-vs-Age(81-100Yrs) |
6.26570000328286E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.685200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.407800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.139220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.126200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.267780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.641600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.96189731127561E-11 |
| Normal-VS-Type2 PRCC |
1.40729983222343E-10 |
| Normal-VS-KIRP CIMP |
9.699700E-02 |
| Normal-VS-Unclassified PRCC |
2.415900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.522600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.902350E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.488600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.442210E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.895650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.771600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14830392259091E-11 |
| Normal-vs-N1 |
3.400300E-03 |
| Normal-vs-N2 |
8.46200000000907E-05 |
| N0-vs-N1 |
1.231620E-01 |
| N0-vs-N2 |
4.979000E-01 |
| N1-vs-N2 |
2.616600E-01 |
|
|
